PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis

被引:30
作者
Dou, Yi [1 ]
Hu, Daixing [1 ]
Chen, Yingji [1 ]
Xiong, Wei [1 ]
Xiao, Qi [1 ]
Su, Xinliang [1 ]
机构
[1] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing 400016, Peoples R China
关键词
Papillary thyroid carcinoma (PTC); Lymphatic metastasis; Tumour location; Lymph node dissection; PAPILLARY THYROID-CARCINOMA; RISK-FACTORS; CANCER; GUIDELINES; MANAGEMENT;
D O I
10.1186/s12957-020-01965-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundLateral lymph node metastasis (LLNM) is very common in papillary thyroid carcinoma (PTC). The influence of tumour location on LLNM remains controversial. The purpose of this study was to reveal the association between PTC tumours located in the upper pole and LLNM.MethodsWe reviewed a total of 1773 PTC patients who underwent total thyroidectomy with central and lateral lymph node dissection between 2013 and 2018. Patients were divided into two groups according to tumour location. Univariate and multivariate analyses were performed to identify risk factors associated with LLNM and "skip metastasis".ResultsIn the upper pole group, LLNM and skip metastasis were significantly likely to occur. Multivariate analysis showed that tumours located in the upper pole, male sex, extrathyroidal extension (ETE), central lymph node metastasis (CLNM) and tumour size were independent risk factors for LLNM, with odds ratios ([ORs], 95% confidence intervals [CIs]) of 2.136 (1.707-2.672), 1.486 (1.184-1.867), 1.332 (1.031-1.72), 4.172 (3.279-5.308) and 2.496 (1.844-3.380), respectively. Skip metastasis was significantly associated with the primary tumour location in the upper pole and age > 55years, with ORs of 4.295 (2.885-6.395) and 2.354 (1.522-3.640), respectively.ConclusionsIn our opinion, papillary thyroid tumours located in the upper pole may have an exclusive drainage pathway to the lateral lymph nodes. When the tumour is located in the upper pole, lateral neck dissection should be evaluated meticulously.
引用
收藏
页数:7
相关论文
共 31 条
[1]  
[Anonymous], 2018, SEER CANC STAT REV 1
[2]   Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review [J].
Attard, Andrea ;
Paladino, Nunzia Cinzia ;
Lo Monte, Attilio Ignazio ;
Falco, Nicola ;
Melfa, Giuseppina ;
Rotolo, Giulia ;
Rizzuto, Stefano ;
Gulotta, Eliana ;
Salamone, Giuseppe ;
Bonventre, Sebastiano ;
Scerrino, Gregorio ;
Cocorullo, Gianfranco .
BMC SURGERY, 2019, 18 (Suppl 1)
[3]   Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis [J].
Back, Kyorim ;
Kim, Jee Soo ;
Kim, Jung-Han ;
Choe, Jun-Ho .
ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (12) :3992-4001
[4]   Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer [J].
Fraser, Sheila ;
Zaidi, Nisar ;
Norlen, Olov ;
Glover, Anthony ;
Kruijff, Schelto ;
Sywak, Mark ;
Delbridge, Leigh ;
Sidhu, Stan B. .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) :3587-3592
[5]   Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients [J].
Gambardella, Claudio ;
Tartaglia, Ernesto ;
Nunziata, Anna ;
Izzo, Graziella ;
Siciliano, Giuseppe ;
Cavallo, Fabio ;
Mauriello, Claudio ;
Napolitano, Salvatore ;
Thomas, Guglielmo ;
Testa, Domenico ;
Rossetti, Gianluca ;
Sanguinetti, Alessandro ;
Avenia, Nicola ;
Conzo, Giovanni .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
[6]   Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy [J].
Gong, Yanping ;
Yang, Jing ;
Yan, Shuping ;
Su, Anping ;
Liu, Feng ;
Gong, Rixiang ;
Zhu, Jingqiang ;
Li, Zhihui .
MEDICINE, 2018, 97 (36)
[7]   NCCN Guidelines® Insights Thyroid Carcinoma, Version 2.2018 Featured Updates to the NCCN Guidelines [J].
Haddad, Robert I. ;
Nasr, Christian ;
Bischoff, Lindsay ;
Busaidy, Naifa Lamki ;
Byrd, David ;
Callender, Glenda ;
Dickson, Paxton ;
Duh, Quan-Yang ;
Ehya, Hormoz ;
Goldner, Whitney ;
Haymart, Megan ;
Hoh, Carl ;
Hunt, Jason P. ;
Iagaru, Andrei ;
Kandeel, Fouad ;
Kopp, Peter ;
Lamonica, Dominick M. ;
McIver, Bryan ;
Raeburn, Christopher D. ;
Ridge, John A. ;
Ringel, Matthew D. ;
Scheri, Randall P. ;
Shah, Jatin P. ;
Sippel, Rebecca ;
Smallridge, Robert C. ;
Sturgeon, Cord ;
Wang, Thomas N. ;
Wirth, Lori J. ;
Wong, Richard J. ;
Johnson-Chilla, Alyse ;
Hoffmann, Karin G. ;
Gurski, Lisa A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (12) :1429-1440
[8]   What is the Appropriate Extent of Lateral Neck Dissection in the Treatment of Metastatic Well-Differentiated Thyroid Carcinoma? [J].
Hasney, Christian P. ;
Amedee, Ronald G. .
LARYNGOSCOPE, 2010, 120 (09) :1716-1717
[9]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133
[10]   Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma [J].
Hu, Daixing ;
Lin, Huapeng ;
Zeng, Xuan ;
Wang, Tielin ;
Deng, Jie ;
Su, Xinliang .
WORLD JOURNAL OF SURGERY, 2020, 44 (05) :1498-1505